Ident. | Authors (with country if any) | Title |
---|
000000 (2020) |
Olynka Vega-Vega [Mexique] ; Mauricio Arvizu-Hernández [Mexique] ; José Guillermo Domínguez-Cherit [Mexique] ; Juan Sierra-Madero [Mexique] ; Ricardo Correa-Rotter [Mexique] | [Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units.] |
000002 (2020) |
Ritesh Gupta [Inde] ; Anoop Misra [Inde] | Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). |
000003 (2020) |
Manish Bansal [Inde] | Cardiovascular disease and COVID-19. |
000004 (2020) |
S. Harikrishnan [Inde] ; P P Mohanan [Inde] ; V K Chopra [Inde] ; Roy Ambuj [Inde] ; G. Sanjay [Inde] ; Manish Bansal [Inde] ; R N Chakraborty [Inde] ; Sharad Chandra [Inde] ; S S Chattarjee [Inde] ; H K Chopra ; Cibu Mathew [Inde] ; P K Deb [Inde] ; A. Goyal [Inde] ; K C Goswami [Inde] ; R. Gupta [Inde] ; S. Guha [Inde] ; V. Gupta [Inde] ; P K Hasija [Inde] ; Harsh Wardhan [Inde] ; A. Jabir [Inde] ; P B Jayagopal [Inde] ; D. Kahali [Inde] ; V K Katyal [Inde] ; P G Kerkar [Inde] ; N N Khanna [Inde] ; B. Majumder [Inde] ; M. Mandal [Inde] ; C B Meena [Inde] ; N. Naik [Inde] ; V K Narain [Inde] ; L A Pathak [Inde] ; S. Ray [Inde] ; D. Roy [Inde] ; S N Routray [Inde] ; D. Sarma [Inde] ; S. Shanmugasundaram [Inde] ; B P Singh [Inde] ; S K Tyagi [Inde] ; K. Venugopal [Inde] ; G S Wander [Inde] ; Rakesh Yadav [Inde] ; M K Das [Inde] | Cardiological society of India position statement on COVID-19 and heart failure. |
000005 (2020) |
Iva Golemi Minga [États-Unis] ; Lolita Golemi [États-Unis] ; Alfonso Tafur [États-Unis] ; Amit Pursnani [États-Unis] | The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease. |
000006 (2020) |
Yong-Jian Geng [États-Unis] ; Zhi-Yao Wei [République populaire de Chine] ; Hai-Yan Qian [République populaire de Chine] ; Ji Huang [République populaire de Chine] ; Robert Lodato [États-Unis] ; Richard J. Castriotta [États-Unis] | Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. |
000007 (2020) |
Awadhesh Kumar Singh [Inde] ; Ritesh Gupta [Inde] ; Anoop Misra [Inde] | Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. |
000010 (2020) |
Meryem Aktoz ; Hakan Altay ; Emre Aslanger ; Enver Atalar ; Lyas Atar ; Vedat Aytekin ; Ahmet Oytun Baykan ; Cem Barç N ; Nezihi Bar ; Asiyeayça Boyac ; Yüksel Çavu O Lu ; Ahmet Çelik ; Göksel Çinier ; Muzaffer De Ertekin ; Sabri Demircan ; Önder Ergönül ; Mehmet Ertürk ; M Kemal Erol ; Bülent Görenek ; Mustafa Ozan Gürsoy ; Burak Hünük ; Gökhan Kahveci ; Can Yücel Karabay ; Ilg N Karaca ; Meral Kay Kç O Lu ; Muhammed Keskin ; Teoman K L Ç ; Burçak K L Çk Ranavc ; Cevat K Rma ; Umut Kocaba ; Derya Kocakaya ; Serdar Küçüko Lu ; Bülent Mutlu ; Sanem Nalbantgil ; Ertu Rul Okuyan ; Kaan Okyay ; Deniz Kaptanözen ; Sami Özgül ; Ebru Özpelit ; Bahar Pirat ; Sena Sert ; Ümit Ya Ar Sinan ; Yusuf Ziya Ener ; Ersan Tatl ; Ahmet Lker Tekke In ; Eralp Tutar ; Dilek Ural ; Özlem Y Ld R Mtürk ; Bedrettin Y Ld Zeli | [Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases (May 13, 2020)]. |
000013 (2020) |
Camilla Alderighi ; Raffaele Rasoini ; Giuseppe Ambrosio ; Serafina Valente ; Gian Franco Gensini | [New insights into the seriousness of acute myocardial injury during COVID-19]. |
000015 (2020) |
| [Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19]. |
000017 (2020) |
Meryem Aktoz ; Hakan Altay ; Emre Aslanger ; Enver Atalar ; Vedat Aytekin ; Ahmet Oytun Baykan ; Cem Barç N ; Nezihi Bar ; Asiye Ayça Boyac ; Yüksel Çavu O Lu ; Ahmet Çelik ; Göksel Çinier ; Muzaffer De Ertekin ; Önder Ergönül ; Mehmet Ertürk ; M Kemal Erol ; Bülent Görenek ; Mustafa Ozan Gürsoy ; Burak Hünük ; Gökhan Kahveci ; Can Yücel Karabay ; Ilg N Karaca ; Meral Kay Kç O Lu ; Muhammed Keskin ; Teoman K L Ç ; Cevat K Rma ; Umut Kocaba ; Serdar Küçüko Lu ; Bülent Mutlu ; Sanem Nalbantgil ; Ertu Rul Okuyan ; Kaan Okyay ; Deniz Kaptan Zen ; Sami Özgül ; Ebru Özpelit ; Bahar Pirat ; Sena Sert ; Ümit Ya Ar Sinan ; Yusuf Ziya Ener ; Ersan Tatl ; Ahmet Lker Tekke In ; Eralp Tutar ; Dilek Ural ; Özlem Y Ld R Mtürk | [Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)]. |
000019 (2020) |
Jiahao Zhang [République populaire de Chine] ; Juan Li [Oman] ; Lianjiu Su [République populaire de Chine] ; Jie Yang [Oman] ; Xiaofang Jiang [République populaire de Chine] ; Nanhui Jiang [République populaire de Chine] ; Yu Lei [Oman] ; Li He [République populaire de Chine] ; Qiaofa Lu [Oman] ; Sanying Shen [Oman] ; Fan Chen [Oman] ; Zhiyong Peng [République populaire de Chine] | [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019]. |
000021 (2020) |
Pablo Lamelas [Argentine, Canada] ; Fernando Botto [Argentine] ; Gustavo Pedernera [Argentine] ; Alberto Alves De Lima [Argentine] ; Juan Pablo Costabel [Argentine] ; Jorge Belardi [Argentine] | [Cardiovascular disease in times of COVID-19]. |
000026 (2020) |
Friedrich Thienemann ; Fausto Pinto ; Diederick E. Grobbee ; Michael Boehm [États-Unis] ; Nooshin Bazargani ; Junbo Ge ; Karen Sliwa | World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries. |
000036 (2020) |
Ohad Oren ; Eric H. Yang ; Ty J. Gluckman ; Erin D. Michos ; Roger S. Blumenthal ; Bernard J. Gersh | Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. |
000038 (2020) |
Samia Arshad [États-Unis] ; Paul Kilgore [États-Unis] ; Zohra S. Chaudhry [États-Unis] ; Gordon Jacobsen [États-Unis] ; Dee Dee Wang [États-Unis] ; Kylie Huitsing [États-Unis] ; Indira Brar [États-Unis] ; George J. Alangaden [États-Unis] ; Mayur S. Ramesh [États-Unis] ; John E. Mckinnon [États-Unis] ; William O'Neill [États-Unis] ; Marcus Zervos [États-Unis] | Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. |
000047 (2020) |
Chet Trivedy [Royaume-Uni] ; Ian Mills [Royaume-Uni] ; Onkar Dhanoya [Royaume-Uni] | The impact of the risk of COVID-19 on Black, Asian and Minority Ethnic (BAME) members of the UK dental profession. |
000056 (2020) |
Shashank S. Sinha [États-Unis] ; Garima Sharma [États-Unis] ; Michael W. Cullen [États-Unis] | The Crucible of Crisis: Responses of Fellows-in-Training and Early Career Cardiologists to the COVID-19 Pandemic. |
000063 (2020) |
Sheldon H. Preskorn [États-Unis] | The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy. |
000065 (2020) |
Brian Xiangzhi Wang [Royaume-Uni] | Susceptibility and prognosis of COVID-19 patients with cardiovascular disease. |
000089 (2020) |
Alexander J. Keeley [Royaume-Uni] ; Cariad Evans [Royaume-Uni] ; Hayley Colton [Royaume-Uni] ; Michael Ankcorn [Royaume-Uni] ; Alison Cope [Royaume-Uni] ; Amy State [Royaume-Uni] ; Tracy Bennett [Royaume-Uni] ; Prosenjit Giri [Royaume-Uni] ; Thushan I. De Silva [Royaume-Uni] ; Mohammad Raza [Royaume-Uni] | Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020. |
000091 (2020) |
Lizhen Xu [République populaire de Chine] ; Yaqian Mao [République populaire de Chine] ; Gang Chen [République populaire de Chine] | Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis. |
000098 (2020) |
Christopher N. Floyd [Royaume-Uni] ; Anthony S. Wierzbicki | Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill? |
000099 (2020) |
Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France] | Renin-angiotensin system at the heart of COVID-19 pandemic. |
000100 (2020) |
Giuseppe Mancia ; Federico Rea ; Monica Ludergnani ; Giovanni Apolone ; Giovanni Corrao | Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. |
000101 (2020) |
Jordana B. Cohen [États-Unis] ; Thomas C. Hanff [États-Unis] ; Adam P. Bress [États-Unis] ; Andrew M. South [États-Unis] | Relationship Between ACE2 and Other Components of the Renin-Angiotensin System. |
000103 (2020) |
Hans-Joachim Anders [Allemagne] ; Annette Bruchfeld [Suède] ; Gema Maria Fernandez Juarez [Espagne] ; Jürgen Floege [Allemagne] ; Dimitrios Goumenos [Grèce] ; Kultigin Turkmen [Turquie] ; Cees Van Kooten [Pays-Bas] ; Vladimir Tesar [République tchèque] ; M Rten Segelmark [Suède] | Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic. |
000105 (2020) |
Marco A. Alcocer-Gamba [Mexique] ; Pedro Gutiérrez-Fajardo [Mexique] ; Alejandro Sosa-Caballero [Mexique] ; Alfredo Cabrera-Rayo [Mexique] ; Raquel N. Faradji-Hazan [Mexique] ; Francisco G. Padilla-Padilla [Mexique] ; Juan C. Garnica-Cuellar [Mexique] ; Leticia M. Hernández-Arispe [Mexique] ; Fernando A. Reyes-Cianeros [Mexique] ; Andrés Le N-Suárez [Mexique] ; José De-Jesús-Rivera [Mexique] ; Leonardo Mancillas-Adame [Mexique] ; Manuel Gaxiola-Macias [Mexique] ; Eduardo Márquez-Rodríguez [Mexique] ; Emma Miranda-Malpica [Mexique] ; Valentín Sanchez-Pedraza [Mexique] ; Daniel S. Lara-Martínez [Mexique] ; Antonio Segovia-Palomo [Mexique] ; Angeles Nava-Hernández [Mexique] ; Romina Rivera-Reyes [Mexique] | Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2. |
000107 (2020) |
Ignacio J. Amat-Santos [Espagne] ; Sandra Santos-Martinez [Espagne] ; Diego L Pez-Otero [Espagne] ; Luis Nombela-Franco [Espagne] ; Enrique Gutiérrez-Ibanes [Espagne] ; Raquel Del Valle [Espagne] ; Erika Mu Oz-García [Espagne] ; Víctor A. Jiménez-Diaz [Espagne] ; Ander Regueiro [Espagne] ; Rocío González-Ferreiro [Espagne] ; Tomás Benito [Espagne] ; Xoan Carlos Sanmartin-Pena [Espagne] ; Pablo Catalá [Espagne] ; Tania Rodríguez-Gabella [Espagne] ; Jose Raúl Delgado-Arana [Espagne] ; Manuel Carrasco-Moraleja [Espagne] ; Borja Iba Ez [Espagne] ; J Alberto San Román [Espagne] | Ramipril in High-Risk Patients With COVID-19. |
000110 (2020) |
Robert A. Harrington ; John J. Warner | Protecting Our Front Line. |
000114 (2020) |
Maryam Aboughdir [Royaume-Uni] ; Thomas Kirwin [Royaume-Uni] ; Ashiq Abdul Khader [Royaume-Uni] ; Brian Wang [Royaume-Uni] | Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review. |
000117 (2020) |
Eamon Y. Duffy [États-Unis] ; Miguel Cainzos-Achirica [États-Unis] ; Erin D. Michos [États-Unis] | Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic. |
000119 (2020) |
Jing Yang [République populaire de Chine] ; Ya Zheng [République populaire de Chine] ; Xi Gou [République populaire de Chine] ; Ke Pu [République populaire de Chine] ; Zhaofeng Chen [République populaire de Chine] ; Qinghong Guo [République populaire de Chine] ; Rui Ji [République populaire de Chine] ; Haojia Wang [République populaire de Chine] ; Yuping Wang [République populaire de Chine] ; Yongning Zhou [République populaire de Chine] | Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. |
000123 (2020) |
Yong Hu [République populaire de Chine] ; Jiazhong Sun [République populaire de Chine] ; Zhe Dai [République populaire de Chine] ; Haohua Deng [République populaire de Chine] ; Xin Li [République populaire de Chine] ; Qi Huang [République populaire de Chine] ; Yuwen Wu [République populaire de Chine] ; Li Sun [République populaire de Chine] ; Yancheng Xu [République populaire de Chine] | Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. |
000129 (2020) |
Vageesh Jain [Royaume-Uni] ; Jin-Min Yuan [Royaume-Uni] | Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. |
000133 (2020) |
Giuseppe Lippi [Italie] ; Brandon M. Henry [États-Unis] ; Fabian Sanchis-Gomar [Espagne, États-Unis] | Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). |
000137 (2020) |
Dilek Dilli [Turquie] ; Irfan Ta O Lu [Turquie] | Perioperative care of the newborns with CHDs in the time of COVID-19. |
000148 (2020) |
Qingxian Cai [République populaire de Chine] ; Fengjuan Chen [République populaire de Chine] ; Tao Wang [République populaire de Chine] ; Fang Luo [République populaire de Chine] ; Xiaohui Liu [République populaire de Chine] ; Qikai Wu [République populaire de Chine] ; Qing He [République populaire de Chine] ; Zhaoqin Wang [République populaire de Chine] ; Yingxia Liu [République populaire de Chine] ; Lei Liu [République populaire de Chine] ; Jun Chen [République populaire de Chine] ; Lin Xu [République populaire de Chine] | Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. |
000162 (2020) |
María Martinez-Ferran [Espagne] ; Fernando De La Guía-Galipienso [Espagne] ; Fabián Sanchis-Gomar [Espagne, États-Unis] ; Helios Pareja-Galeano [Espagne] | Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits. |
000166 (2020) |
Edyta Pło Ska-Go Ciniak [Pologne] ; Piotr Suwalski [Pologne] ; Stanisław Bartu [Pologne] ; Tomasz Kukulski [Pologne] ; Monika Komar [Pologne] ; Wojciech Wojakowski [Pologne] ; Marek Grygier [Pologne] ; Piotr Pruszczyk [Pologne] ; Zbigniew G Sior [Pologne] ; Zenon Huczek [Pologne] ; Adrianna Berger-Kucza [Pologne] ; Janusz B K [Pologne] ; Danuta Sorysz [Pologne] ; Jarosław D. Kasprzak [Pologne] | Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society. |
000172 (2020) |
Virna Margarita Martín Giménez [Argentine] ; Felipe Inserra [Argentine] ; Carlos D. Tajer [Argentine] ; Javier Mariani [Argentine] ; Le N Ferder [Argentine] ; Russel J. Reiter [États-Unis] ; Walter Manucha [Argentine] | Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. |
000174 (2020) |
Edoardo Sciatti [Italie] ; Claudio Ceconi [Italie] | Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19. |
000177 (2020) |
Antonio Ceriello [Italie] ; Eberhard Standl [Allemagne] ; Doina Catrinoiu [Roumanie] ; Baruch Itzhak [Israël] ; Nebojsa M. Lalic [Serbie] ; Dario Rahelic [Croatie] ; Oliver Schnell [Allemagne] ; Jan Škrha [République tchèque] ; Paul Valensi | Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era. |
000182 (2020) |
Hisashi Kai [Japon] ; Mamiko Kai [Japon] | Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. |
000199 (2020) |
Ankeet S. Bhatt [États-Unis] ; Alea Moscone [États-Unis] ; Erin E. Mcelrath [États-Unis] ; Anubodh S. Varshney [États-Unis] ; Brian L. Claggett [États-Unis] ; Deepak L. Bhatt [États-Unis] ; James L. Januzzi [États-Unis] ; Javed Butler [États-Unis] ; Dale S. Adler [États-Unis] ; Scott D. Solomon [États-Unis] ; Muthiah Vaduganathan [États-Unis] | Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic. |
000202 (2020) |
Himanshu Sankrityayan [Inde] ; Ajinath Kale [Inde] ; Nisha Sharma [Inde] ; Hans-Joachim Anders [Allemagne] ; Anil Bhanudas Gaikwad [Inde] | Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder. |
000209 (2020) |
Yongli Zheng [République populaire de Chine] ; Hong Xu [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Yilan Zeng [République populaire de Chine] ; Hong Chen [République populaire de Chine] ; Ru Liu [République populaire de Chine] ; Qingfeng Li [République populaire de Chine] ; Na Zhang [République populaire de Chine] ; Dan Wang [République populaire de Chine] | Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. |
000214 (2020) |
Gregorio Tersalvi [Suisse] ; Marco Vicenzi [Italie] ; Davide Calabretta [Italie] ; Luigi Biasco [Suisse] ; Giovanni Pedrazzini [Suisse] ; Dario Winterton [Italie] | Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. |
000227 (2020) |
Yiwu Zhou [République populaire de Chine] ; Yanqi He [République populaire de Chine] ; Huan Yang [République populaire de Chine] ; He Yu [République populaire de Chine] ; Ting Wang [République populaire de Chine] ; Zhu Chen [République populaire de Chine] ; Rong Yao [République populaire de Chine] ; Zongan Liang [République populaire de Chine] | Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China. |
000233 (2020) |
Ajay K. Gupta ; Hani Jneid ; Daniel Addison ; Hossein Ardehali ; Amelia K. Boehme ; Sanket Borgaonkar ; Romain Boulestreau ; Kevin Clerkin ; Nicolas Delarche ; Holli A. Devon ; Isabella M. Grumbach ; Jose Gutierrez ; Daniel A. Jones ; Vikas Kapil ; Carmela Maniero ; Amgad Mentias ; Pamela S. Miller ; Sher May Ng ; Jai D. Parekh ; Reynaldo H. Sanchez ; Konrad Teodor Sawicki ; Anneline S J M. Te Riele ; Carol Ann Remme ; Barry London | Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors. |
000235 (2020) |
Francesco P. Cappuccio [Royaume-Uni] ; Alfonso Siani [Italie] | Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint. |